Navigation Links
MPs in Biological Technology

Mach One Subsidiary Modular Process Constructors LLC Changes Name to MPS BioPharm to Better Reflect its Vision

Announces significant contract with Major Biopharmaceutical Company BELGIUM, Wis., March 6 /PRNewswire-FirstCall/ -- Mach One Corporation (Pink Sheets: MNCN), is pleased to announce that its subsidiary, Modular Process Constructors LLC, is changing its name to MPS BioPharm to better reflect i...

BioMarin Announces Program for ERT for Treatment of MPS IVA - Morquio A Syndrome

NOVATO, Calif., June 5 /PRNewswire-FirstCall/ - BioMarin Pharmaceutical Inc. (Nasdaq and SWX: BMRN) today announced its program for its third enzyme replacement therapy (ERT) for the treatment of mucopolysaccharidosis IVA (MPS IVA), or Morquio A Syndrome. BioMarin plans to initiate a Phase 1/2...

Kuvan Receives Priority Review Status From Health Canada

...ment for the treatment of PKU and GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in Phase 1/2 clinical development for the treatment of mps IVA. For additional information, please visit www.BMRN.com . Information on BioMarin's website is not incorporated by reference into this press relea...

BioMarin to Present at the Jefferies Healthcare Conference

...ent for the treatment of PKU and GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in Phase I/II clinical development for the treatment of mps IVA. For additional information, please visit www.BMRN.com . Information on BioMarin's website is not incorporated by reference into this press relea...

BioMarin to Present at the Goldman Sachs Healthcare Conference

...ent for the treatment of PKU and GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in Phase I/II clinical development for the treatment of mps IVA. For additional information, please visit www.BMRN.com . Information on BioMarin's website is not incorporated by reference into this press relea...

BioMarin to Present at the Deutsche Bank Health Care Conference

...ent for the treatment of PKU and GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in Phase I/II clinical development for the treatment of mps IVA. For additional information, please visit www.BMRN.com . Information on BioMarin's website is not incorporated by reference into this press relea...

BioMarin to Present at the Baird Growth Stock Conference

...ent for the treatment of PKU and GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in Phase I/II clinical development for the treatment of mps IVA. For additional information, please visit www.BMRN.com . Information on BioMarin's website is not incorporated by reference into this press relea...

BioMarin Announces First Quarter 2009 Financial Results

...g programs including PEG-PAL for PKU and GALNS for mps IVA. We are strategically developing earlier stag...ial are expected in mid-2010. GALNS for mps IVA: BioMarin initiated the Phase I/II trial in m... 1H10: Results from Phase I/II trial for GALNS for mps IVA Mid-2010: Results from PEG-PAL Phase I...

Mach One BioPharm Process Operating Group Receives Contract From American Beef Processors

...ilize MPS' Equity by Design (TM) product. mps will evaluate all equipment designs for fit and pu...lated to design, constructability and cleanliness. mps will also provide a final report, identifying budg...id, "Equity by Design(TM) is a program whereby mps provides certain Technical Advisory Services in wh...

BioMarin's Clinical Trial Application for GALNS for Morquio A Syndrome Accepted by the MHRA

...me replacement therapies, one for the treatment of mps I and one for the treatment of mps VI. Naglazyme(R) (galsulfase) for mps VI is wholly developed and commercialized by BioMa...

BioMarin Announces Fourth Quarter and Full Year 2008 Financial Results

...the advancement of several programs including PEG-PAL for PKU and GALNS for mps IVA. We also plan to continue making investments in growth opportunities a...se 2 PAH trial -- 1Q09/2Q09: Initiation of Phase 1 trial for GALNS for mps IVA -- 2Q09: Results from proteinuria in chronic kidney disease trial ...

Naglazyme Approved by Brazil's National Health Surveillance Agency

...zil which has the largest known number of affected mps VI patients in the world," said Stephen Aselage, S...) in January 2006. As the first drug approved for mps VI, the FDA and EC have both designated Naglazyme ...t exclusivity in the European Union. About mps VI ...

Mach One Corporation Enters Letter of Intent

...saction with Modular Process Constructors LLC (dba mps BioPharm) (the "Seller" or "BioPharm") to acquire ... About Modular Process Constructors LLC (dba mps BioPharm) mps BioPharm currently designs and builds skid based s...

Data to Be Presented at 58th Annual Meeting of The American Society of Human Genetics

... (galsulfase) and enzyme replacement therapies for mps IVA (Morquio Syndrome) and Pompe disease will be p...for symptomatic spinal cord compression (SCC) in a mps VI child: safety, efficacy, and pitfalls" 763/W ...ears of Galsulfase ERT in five adult patients with mps VI" 2353/W - "MPS Brazil-Network: 4 years improv...

BioMarin Announces Third Quarter 2008 Financial Results

...xpansion of Naglazyme, and the timely development of the PEG-PAL, GALNS for mps IVA and other promising pipeline programs." Net Product Revenue Net pro...ic kidney disease trial -- 1Q09: Initiation of Phase 1 trial for GALNS for mps IVA -- 1Q09/2Q09: Results from PEG-PAL Phase 1 trial -- 1Q09/2Q09: Initia...

Naglazyme Approved by Japanese Ministry of Health

...Ges in bringing the first drug treatment option to mps VI patients in Japan," said Stephen Aselage, Senio...C) in January 2006. As the first drug approved for mps VI, the FDA and EC have both designated Naglazyme ...ation in June 2007 from the MHLW in Japan. About mps VI ...

BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture

...rojects which could lead to important advances for mps I patients." About mps I mps I is a rare, progressive, heterogeneous, debilitat...

Kuvan, Naglazyme and Aldurazyme Data to Be Presented at the 57th Annual Meeting of the American Society of Human Genetics

...e (galsulfase) Enzyme Replacement Therapy (ERT) in mps VI (Maroteaux-Lamy Syndrome) patients Presented b...sserstein) -- 1495 -- Clinical Characteristics of mps I patients in the mps I Registry (Bodamer) -- 2241 -- Urinary GAG ...

Genzyme Receives Approval to Market Elaprase(R) in Japan

... Cerezyme(R) (imiglucerase for injection) for Type 1 Gaucher disease; Fabrazyme(R) (agalsidase beta) for Fabry disease; Aldurazyme(R) (laronidase) for mps I; and Myozyme(R) (alglucosidase alfa) for Pompe disease. "Our deep experience in Japan in the area of lysosomal storage disorders will enable us to ...

Genzyme Begins Major Expansion of Boston Manufacturing Facility

... alfa) for Pompe disease. Genzyme also performs the filling and packaging for two products manufactured at other sites: Aldurazyme(R) (laronidase) for mps I disease and Thyrogen(R) (thyrotropin alfa for injection), used in the screening of patients who have had thyroid cancer. Genzyme last expanded the s...

Educate, innovate and execute: Wisconsins model for success

...m rather than how much is spent administratively. mps simply spends too much money on employee costs (i....nefits, pension) than is manageable. In fact, the mps Board boosted the tax levy for 2003-'04 by more th...$11 million, or a 5.8 percent increase. This year, mps is projecting a 15% increase as a stopgap to keep ...
Other Tags
(Date:8/20/2014)... Research UK scientists have discovered that acral melanomas the ... Marley,s death are genetically distinct from other more common ... external) published in the journal Pigment Cell & Melanoma ... of the hands, soles of the feet, nail-beds and other ... of melanoma, it,s not caused by UV damage from the ...
(Date:8/20/2014)... past few years, Virginia Tech,s Wu Feng has built ... from the "Computing in the Cloud" program, and synergistically ... million award from the Air Force on "big computing" ... and the National Institutes of Health on "big data" ... the "parallel computing" aspects from each grant, he was ...
(Date:8/20/2014)... colony of honeybees grows to about 4,000 members, it ... the building of a special type of comb used ... experts from the Department of Neurobiology and Behaviour at ... the reproductive cycle of honeybee colonies. The results are ... of Nature . , Reproduction isn,t always a ...
Breaking Biology News(10 mins):Scientists learn more about rare skin cancer that killed Bob Marley 2The internet was delivered to the masses; parallel computing is not far behind 2The internet was delivered to the masses; parallel computing is not far behind 3The internet was delivered to the masses; parallel computing is not far behind 4Worker bees 'know' when to invest in their reproductive future 2
(Date:8/20/2014)... 2014 Ticket Down is a reliable ... NYC. In just a week, the U.S. Open Tennis Championship ... The event was originally founded in 1881 and features grass courts ... forced to withdrawal from the event because of a wrist injury. ... will return to New York City with hopes of winning her ...
(Date:8/20/2014)... HealthDay Reporter WEDNESDAY, Aug. ... dramatically during the past two decades, plummeting 57 percent and ... An estimated 4 million fewer births occurred among teenagers ... the U.S. Centers for Disease Control and Prevention. That ... report," said Bill Albert, chief program officer of The National ...
(Date:8/20/2014)... examined patient and tumor characteristics for melanomas with ... growth) in an effort to increase earlier detection ... , Author: Sarah Shen, M.B.B.S., B.Med.Sci., of ... Background: The tumor characteristic known as mitotic ... with prognosis and survival in melanoma patients. However, ...
(Date:8/20/2014)... discovered that the immune system is defective in people suffering ... sufferers have ongoing issues with pain. , The research ... also help to explain why some painkillers may not offer ... up to 10% of the community. There are different ... pain, which often has the greatest impact on sufferers, quality ...
(Date:8/20/2014)... now, Free content, The time to deploy Ebola ... published early online today in Annals of ... of Public Health write that the relentless epidemiologic trajectory ... a public health crisis that shows no signs of ... developed in the last decade, yet the sporadic nature ...
Breaking Medicine News(10 mins):Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 2Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 3Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 4Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 5Health News:Teen Birth Rate Has Dropped Dramatically in Last Two Decades: CDC 2Health News:Teen Birth Rate Has Dropped Dramatically in Last Two Decades: CDC 3Health News:Patient, tumor characteristics for high-mitotic rate melanoma 2Health News:Pain treatments less effective for those with irritable bowel 2Health News:News from Annals of Internal Medicine 2
Other Contents